Author

G. P. Dunn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 4 Research Focus:cell type annotation· 3 Assay:bulk RNA-seq· 2 Research Focus:cell signaling & trafficking· 2 Research Focus:clustering· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2

Frequent Co-Authors

A. H. Kim· 2 shared A. J. Livingstone· 2 shared A. Z. Wang· 2 shared E. C. Leuthardt· 2 shared M. O. Schaettler· 2 shared M. R. Chicoine· 2 shared T. M. Johanns· 2 shared A. A. Petti· 1 shared

Activity by Year

2017-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 43 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

A. H. Kim

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Glioblastoma-infiltrating CD8+ T cells are predominantly a clonally expanded GZMK+ effector population

A. Z. Wang, B. L. Mashimo, M. O. Schaettler, N. D. Sherpa, L. A. Leavitt, A. J. Livingstone, S. M. Khan, M. Li, M. Anzaldua-Campos, J. D. Bradley, E. C. Leuthardt, A. H. Kim, J. L. Dowling, M. R. Chicoine, P. S. Jones, , G. P. Dunn

The paper analyzes TILs in GBM using CITE-seq and scRNA-seq to show that CD8+ T cells are predominantly clonally expanded GZMK+ effector cells, lacking canonical exhaustion.

bioRxiv · Aug 25, 2023 · PreprintImmunology

A dual-fluorescent recombinant for live observation of Herpes simplex-type 1 infection outcomes.

L. F. Domanico, G. P. Dunn, O. Kobiler, M. P. Taylor

This paper constructs a dual-fluorescent HSV-1 recombinant to visualize IE and L gene expression in live cells, revealing insights into lytic and latent infection outcomes.

bioRxiv · Jun 7, 2023 · PreprintMicrobiology

The conventional dendritic cell 1 subset primes CD8+ T cells and traffics tumor antigen to drive anti-tumor immunity in the brain

J. A. Bowman-Kirigin, B. T. Saunders, R. Desai, A. Z. Wang, M. O. Schaettler, C. J. Liu, A. J. Livingstone, D. K. Kobayashi, V. Durai, N. M. Kretzer, G. J. Zipfel, E. C. Leuthardt, J. W. Osbun, M. R. Chicoine, A. H. Kim, , G. P. Dunn

The paper identifies cDC1's role in priming CD8+ T cells and trafficking tumor antigens to drive anti-tumor immunity in the brain.

bioRxiv · Sep 13, 2021Immunology

Temporal and Clonal Progression in a Pediatric Ependymoma Patient Through Multiple Treatments

C. A. Miller, S. Dahiya, T. Li, R. Fulton, M. D. Smyth, G. P. Dunn, J. B. Rubin, E. R. Mardis

This study tracks the molecular evolution of a pediatric ependymoma through multiple treatments, revealing how therapy shapes tumor subclonal diversity and neo-antigen landscapes.

bioRxiv · Mar 11, 2017Cancer Biology